Parallel Advisors, LLC Alaunos Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

  • $3.87 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 20, 2022
SELL
$1.09 - $1.89 $3,246 - $5,628
-2,978 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$1.44 - $2.73 $4,288 - $8,129
2,978 New
2,978 $5,000
Q4 2020

Feb 02, 2021
SELL
$2.09 - $3.09 $20,900 - $30,900
-10,000 Closed
0 $0
Q1 2020

Apr 27, 2020
BUY
$1.9 - $4.98 $19,000 - $49,800
10,000 New
10,000 $24,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email